Sentence examples for compromise outcomes from inspiring English sources

G-CSF prophylaxis is now recommended when the overall risk of febrile neutropenia (FN) due to regimen and individual patient factors is >or=20%, for supporting dose-dense and dose-intense chemotherapy and to help maintain dose density where dose reductions have been shown to compromise outcomes.

Overall, reduced availability of fungicidal drugs continues to compromise outcomes in high-burden countries.

Although the sample size was too small to draw conclusions, ovarian preservation did not seem to compromise outcomes.

Through education and outreach a majority of good-prognosis patients can be persuaded to accept SET (Ryan et al., 2007) but many are reluctant to compromise outcomes.

Lastly, from both the therapist and participant perspectives, our results indicate that the video conferencing format did not compromise outcomes with regard to mood or thematic content of the sessions.

Such plots identify studies in the appropriate quadrant (i.e. those that reduce costs without compromising outcomes) and those in problematic quadrants (i.e. those that reduce costs but also compromise outcomes, or those that compromise both outcomes and costs).

(Justice Ruth Bader Ginsburg's devastating dissenting opinion last week read to me as if major portions had been written back in 2009, rendered unnecessary by the compromise outcome then, but saved for the day that she knew was coming).

This indicates that omission of chemotherapy in these patients may not compromise outcome.

There is controversy regarding the optimal time of intervention, with some authorities recommending early intervention [ 46, 47] and others suggesting that late augmentation does not compromise outcome [ 23, 48].

Cross-trial comparisons between Vogel et al.'s study [ 8] and the pivotal phase III study [ 5] suggest that the use of herceptin as monotherapy in FISH-positive patients rather than in combination may not ultimately compromise outcome.

40– 43 Furthermore, secondary prophylaxis is warranted in patients who have developed febrile neutropenia with previous cycles of chemotherapy, particularly in the curative intent setting of (neo)adjuvant therapy where dose reduction may compromise outcome.